Exebacase in Addition to Standard-of-Care Antibiotics for Staphylococcus aureus Bloodstream Infections and Right-Sided Infective Endocarditis: A Phase 3, Superiority-Design, Placebo-Controlled, Randomized Clinical Trial (DISRUPT)
Work
Year: 2024
Type: article
Abstract: Background Novel treatments are needed for Staphylococcus aureus bacteremia, particularly for methicillin-resistant S. aureus (MRSA). Exebacase is a first-in-class antistaphylococcal lysin that is ra... more
Source: Clinical Infectious Diseases
Institutions Duke Medical Center, West County Health Centers, ContraFect (United States), Enzo Life Sciences (United States), Mercy St. Vincent Medical Center +12 more
Cites: 18
Cited by: 12
Related to: 10
FWCI: 11.69
Citation percentile (by year/subfield): 99.99
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: bronze